LAUSR

DOI: 10.5935/abc.20180232 With the aging of the world’s population, there has been a parallel growth of valvular heart disease. The development and establishment of less-invasive transcatheter aortic valve replacement (TAVR) has provided a different framework to approach these patients through a multi-disciplinary heart team for planning and treatment. This multi-disciplinary heart team allows the sharing of different expertise and knowledge in order to improve patient care. Although TAVR is one example, many other transcatheter structural heart interventions for the mitral valve, left atrial appendage, paravalvular leak closure, and tricuspid valve, will continue to expand the armamentarium of less-invasive therapies for these typically high-risk patients.